Dashboard
Manage Tickers

CRLCHARLES RIVER LABORATORIES ...

NYSE criver.com


$ 206.49 $ -3.46 (-1.65 %)    

Tuesday, 25-Jun-2024 15:59:57 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.35 $ 5.42 (1.14 %)
DIA $ 391.06 $ -2.96 (-0.75 %)
SPY $ 544.78 $ 2.09 (0.39 %)
TLT $ 94.49 $ 0.16 (0.17 %)
GLD $ 214.55 $ -1.07 (-0.5 %)
$ 206.39
$ 208.01
$ 0.00 x 0
$ 0.00 x 0
$ 204.00 - $ 209.70
$ 161.65 - $ 275.00
454,389
na
10.7B
$ 1.34
$ 24.07
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-30-2024 10-Q
2 02-14-2024 12-30-2023 10-K
3 11-08-2023 09-30-2023 10-Q
4 08-09-2023 07-01-2023 10-Q
5 05-11-2023 04-01-2023 10-Q
6 02-22-2023 12-31-2022 10-K
7 11-02-2022 09-24-2022 10-Q
8 08-03-2022 06-25-2022 10-Q
9 05-04-2022 03-26-2022 10-Q
10 02-16-2022 12-25-2021 10-K
11 11-03-2021 09-25-2021 10-Q
12 08-04-2021 06-26-2021 10-Q
13 05-04-2021 03-27-2021 10-Q
14 02-17-2021 12-26-2020 10-K
15 11-09-2020 09-26-2020 10-Q
16 10-29-2020 09-26-2020 10-Q
17 08-05-2020 06-27-2020 10-Q
18 05-07-2020 03-28-2020 10-Q
19 02-11-2020 12-28-2019 10-K
20 11-06-2019 09-28-2019 10-Q
21 07-31-2019 06-29-2019 10-Q
22 05-07-2019 03-30-2019 10-Q
23 02-13-2019 12-29-2018 10-K
24 11-07-2018 09-29-2018 10-Q
25 08-08-2018 06-30-2018 10-Q
26 05-10-2018 03-31-2018 10-Q
27 02-13-2018 12-30-2017 10-K
28 11-09-2017 09-30-2017 10-Q
29 08-09-2017 07-01-2017 10-Q
30 05-10-2017 04-01-2017 10-Q
31 02-14-2017 12-31-2016 10-K
32 11-02-2016 09-24-2016 10-Q
33 08-03-2016 06-25-2016 10-Q
34 05-04-2016 03-26-2016 10-Q
35 02-12-2016 12-26-2015 10-K
36 11-04-2015 09-26-2015 10-Q
37 07-30-2015 06-27-2015 10-Q
38 04-30-2015 03-28-2015 10-Q
39 02-17-2015 12-27-2014 10-K
40 10-30-2014 09-27-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

charles-river-laboratories-announces-strategic-lentiviral-vector-manufacturing-collaboration-with-gates-institute-at-university-of-colorado-anschutz-medical-campus
Charles River Laboratories Announces Strat...
06/25/2024 12:11:19

Lentiviral vector CDMO collaboration to support advanced cell therapies for hematological cancersCharles River Laboratories Int...

charles-river-laboratories-and-captain-t-cell-announce-plasmid-dna-and-retrovirus-vector-production-agreement-captain-t-cell-to-utilize-charles-rivers-cgt-accelerator-program-for-phase-i-clinical-trial-of-tcr-t-cell-therapy-for-solid-tumors
Charles River Laboratories And Captain T C...
06/17/2024 12:06:23

charles-river-laboratories-in-collaboration-with-mattek-awarded-13m-grant-from-the-foundation-for-chemistry-research-and-initiatives-to-advance-research-alternatives
Charles River Laboratories In Collaboratio...
06/11/2024 12:19:15

Project will utilize an integrated approach to develop an in vitro alternative to inhalation toxicology studiesCharles River La...

mizuho-initiates-coverage-on-charles-river-with-neutral-rating-announces-price-target-of-235
Mizuho Initiates Coverage On Charles River...
06/07/2024 10:42:02

Mizuho analyst Ann Hynes initiates coverage on Charles River (NYSE:CRL) with a Neutral rating and announces Price Target of ...

the-analyst-verdict-charles-river-in-the-eyes-of-4-experts
The Analyst Verdict: Charles River In The ...
06/06/2024 13:00:46

goldman-sachs-initiates-coverage-on-charles-river-with-buy-rating-announces-price-target-of-290
Goldman Sachs Initiates Coverage On Charle...
06/06/2024 12:57:36

Goldman Sachs analyst Matthew Sykes initiates coverage on Charles River (NYSE:CRL) with a Buy rating and announces Price Tar...

charles-river-laboratories-announces-opening-of-new-cradl-facility-in-somerville-massachusetts-an-emerging-life-sciences-hub
Charles River Laboratories Announces Openi...
06/06/2024 12:14:25

charles-river-introduces-its-vector-tech-transfer-program-to-safeguard-gene-therapy-development
Charles River Introduces Its Vector Tech T...
05/30/2024 12:02:56

Fast Track and Modular frameworks facilitate product development continuity via seamless process transfer to the Company's ...

td-cowen-maintains-hold-on-charles-river-lowers-price-target-to-228
TD Cowen Maintains Hold on Charles River, ...
05/13/2024 16:18:45

TD Cowen analyst Charles Rhyee maintains Charles River (NYSE:CRL) with a Hold and lowers the price target from $260 to $228.

the-analyst-landscape-7-takes-on-charles-river
The Analyst Landscape: 7 Takes On Charles ...
05/10/2024 12:00:43

baird-maintains-outperform-on-charles-river-lowers-price-target-to-270
Baird Maintains Outperform on Charles Rive...
05/10/2024 11:21:34

Baird analyst Eric Coldwell maintains Charles River (NYSE:CRL) with a Outperform and lowers the price target from $282 to $270.

charles-river-laboratories-reaffirms-outlook-for-fy24-revenue-growth-of-10-40-and-adj-eps-of-1090-1140-est-1102
Charles River Laboratories Reaffirms Outlo...
05/09/2024 11:11:24

 Despite modest adjustments to the quarterly gating in 2024, the Company's outlook for the year remains essentially unchang...

charles-river-q1-2024-adj-eps-227-beats-207-estimate-sales-1011b-beat-992270m-estimate
Charles River Q1 2024 Adj EPS $2.27 Beats ...
05/09/2024 11:02:38

Charles River (NYSE:CRL) reported quarterly earnings of $2.27 per share which beat the analyst consensus estimate of $2.07 by 9...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
05/07/2024 17:35:23

charles-river-launches-viral-vector-reference-materials-to-streamline-the-transition-to-gmp
Charles River Launches Viral Vector Refere...
05/02/2024 12:14:25

Supporting scale-up for early-phase AAV- and LVV-based gene and gene-modified cell therapy researchers and developersCharles Ri...

Core News & Articles
FibroBiologics, Charles River Laboratories...
04/25/2024 12:02:58

This agreement comes ahead of entering into an anticipated master services agreement for the development and manufacture of Fib...

charles-river-laboratories-launches-alternative-methods-advancement-project-to-reduce-reliance-on-animal-testing
Charles River Laboratories Launches Altern...
04/16/2024 12:04:39

charles-river-to-perform-plasmid-production-for-ship-of-theseus
Charles River To Perform Plasmid Productio...
04/04/2024 12:09:49

GMP grade plasmid DNA to serve as a direct therapeutic targeting various indicationsCharles River Laboratories International, I...

charles-river-announces-extension-of-gene-therapy-manufacturing-alliance-with-nus-yong-loo-lin-school-of-medicine
Charles River Announces Extension Of Gene ...
03/21/2024 12:04:57

evaluating-charles-river-insights-from-7-financial-analysts
Evaluating Charles River: Insights From 7 ...
03/18/2024 18:01:03

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)